Incidental prostate cancer in patients with bladder urothelial carcinoma: Comprehensive analysis of 1,476 radical cystoprostatectomy specimens

Journal of Urology

Volumn 190, Issue 5, 2013, Pages 1704-1709

  Bruins, Harman Maxim ^a   Djaladat, Hooman ^b   Ahmadi, Hamed ^b   Sherrod, Andy ^b   Cai, Jie ^b   Miranda, Gus ^b   Skinner, Eila Curlee ^c   Daneshmand, Siamak ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Carcinoma; Cystectomy; Prostatic neoplasms; Urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CYSTECTOMY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RECURRENCE FREE SURVIVAL; RISK FACTOR; TRANSITIONAL CELL CARCINOMA;

EID: 84888640034     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.034     Document Type: Article

References (25)

1. Rozet F, Lesur G, Cathelineau X et al: Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results. J Urol 2008; 179: 2170.
2. Botto H, Sebe P, Molinie V et al: Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int 2004; 94: 1021.
3. Colombo R, Bertini R, Salonia A et al: Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 2004; 171: 1819.
4. Hautmann RE and Stein JP: Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am 2005; 32: 177.
5. Pettus JA, Al-Ahmadie H, Barocas DA et al: Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008; 53: 370.
6. Barbisan F, Mazzuchelli R, Scarpelli M et al: Urothelial and incidental prostate carcinoma in prostates from cystoprostectomies for bladder cancer: is there a relationship between urothelial and prostate cancer. BJU Int 2009; 103: 1058.
7. Revelo MP, Cookson MS, Chang SS et al: Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171: 646.
8. Ruffion A, Manel A, Massoud W et al: Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 2005; 65: 703.
9. Winkler MH, Livni N, Mannion EM et al: Characteristic of prostatic incidental adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 2007; 99: 544.
10. Ward JF, Bartsch G, Sebo TJ et al: Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2ng/ml) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol 2004; 22: 40.
11. Richards KA, Parks GE, Badlani GH et al: Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens. Urology 2010; 75: 1116.
12. Damiano R, Di Lorenzo G, Cantiello F et al: Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur Urol 2007; 52: 648.
13. Sobin LH and Wittekind C: TNM Atlas, 6th ed. New York: Wiley-Liss 2002.
14. Epstein JI, Allsbrook WC Jr, Amin MB et al: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228.
15. Bostwick DG and Cheng L: Precursors of prostate cancer. Histopathology 2012; 60: 4.
16. Aydin O, Cosar EF, Varinli S et al: Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases). Int Urol Nephrol 1999; 31: 687.
17. Wiley EL, Davidson P, McIntire DD et al: Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Urology 1997; 46: 692.
18. Shen SS, Lerner SP, Muezzinoglu B et al: Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37: 726.
19. Esrig D, Freeman JA, Elmajian DA et al: Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156: 1071.
20. Ayyathurai R, Gomez P, Luongo T et al: Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy. BJU Int 2007; 100: 1021.
21. Pagano F, Bassi P, Ferrante GL et al: Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155: 244.
22. Edge SB, Byrd DR, Compton CC et al: Urinary Bladder AJCC Cancer Staging Manual, 7th ed. New York: Springer 2010; p 497.
23. Arce J, Gaya JM, Huguet J et al: Can we identify those patients who will benefit from prostatesparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Can J Urol 2011; 18: 5529.
24. Voigt S, Huttig F, Koch R et al: Risk factors for incidental prostate cancerdwho should not undergo vaporization of the prostate for benign prostate hyperplasia? Prostate 2011; 71: 1325.
25. de Vries RR, Nieuwenhuijzen JA, van Tinteren H et al: Prostate-sparing cystectomy: long-term oncological results. BJU Int 2009; 104: 1239.